The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Impact of the EndoPredict-clin score on risk stratification in ER-positive, HER2-negative breast cancer after considering clinical guidelines.
Martin Filipits
Honoraria - Sividon Diagnostics GmbH
Peter Christian Dubsky
Honoraria - Sividon Diagnostics GmbH
Margaretha Rudas
Honoraria - Sividon Diagnostics GmbH
Jan C. Brase
Employment or Leadership Position - Sividon Diagnostics GmbH
Ralf Kronenwett
Employment or Leadership Position - Sividon Diagnostics GmbH
Karsten E. Weber
Employment or Leadership Position - Sividon Diagnostics GmbH
Christoph Petry
Employment or Leadership Position - Sividon Diagnostics GmbH
Marcus Schmidt
Honoraria - Sividon Diagnostics GmbH
Irmard Luisser
No relevant relationships to disclose
Evelyn Klug
No relevant relationships to disclose
Michael Gnant
No relevant relationships to disclose